CONSOLIDATED CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)		Total	Preferred Stock Series A	Common Stock		Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total Shareholders’ Equity (Deficit) Attributable to 60P	Noncontrolling Interest on Shareholders
Balance at Dec. 31, 2024		$ 3,955,006	$ 9,567,439	$ 14	[1]	$ 34,860,633	$ (40,527,957)	$ 135,471	$ 4,035,600	$ (80,594)
Balance (in Shares) at Dec. 31, 2024			76,480	141,749	[1]
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6)		804,346		$ 5	[1]	804,341			804,346
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)	[1]			51,079
Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6)		908,627		$ 8	[1]	908,619			908,627
Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)	[1]			75,176
Issuance of common stock upon exercise of Pre-Funded Warrants		1,926		$ 9	[1]	1,917			1,926
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)	[1]			96,300
Issuance of shares for annual performance bonuses, net of shares withheld for taxes		103,544				103,544			103,544
Issuance of shares for annual performance bonuses, net of shares withheld for taxes (in Shares)	[1]			3,953
Share rounding adjustment for Reverse Stock Split (in Shares)	[1]			(7)
Share-based compensation expense		142,645				142,645			142,645
Net foreign translation gain (loss)		(9,904)						(9,904)	(9,904)
Net loss		(1,877,301)					(1,876,549)		(1,876,549)	(752)
Balance at Mar. 31, 2025		4,028,889	$ 9,567,439	$ 36	[1]	36,821,699	(42,404,506)	125,567	4,110,235	(81,346)
Balance (in Shares) at Mar. 31, 2025			76,480	368,250	[1]
Balance at Dec. 31, 2025		3,379,416	$ 9,567,439	$ 116		41,646,139	(47,893,115)	142,598	3,463,177	(83,761)
Balance (in Shares) at Dec. 31, 2025			76,480	1,163,142
Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs (Note 6)		3,369,752		$ 148		3,369,604			3,369,752
Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)				1,473,708
Share rounding adjustment for Reverse Stock Split (in Shares)				(62)
Share-based compensation expense		79,524				79,524			79,524
Net foreign translation gain (loss)		5,942						5,942	5,942
Net loss		(2,090,155)					(2,089,214)		(2,089,214)	(941)
Balance at Mar. 31, 2026		$ 4,744,479	$ 9,567,439	$ 264		$ 45,095,267	$ (49,982,329)	$ 148,540	$ 4,829,181	$ (84,702)
Balance (in Shares) at Mar. 31, 2026			76,480	2,636,788

[1] Prior periods presented have been adjusted to reflect the 1:4 reverse stock split on January 20, 2026.